AUTL
Price
$2.41
Change
-$0.01 (-0.41%)
Updated
Jul 18 closing price
Capitalization
641.39M
10 days until earnings call
GNTA
Price
$3.77
Change
-$0.01 (-0.26%)
Updated
Jul 18 closing price
Capitalization
68.95M
Interact to see
Advertisement

AUTL vs GNTA

Header iconAUTL vs GNTA Comparison
Open Charts AUTL vs GNTABanner chart's image
Autolus Therapeutics
Price$2.41
Change-$0.01 (-0.41%)
Volume$1.5M
Capitalization641.39M
Genenta Science SpA
Price$3.77
Change-$0.01 (-0.26%)
Volume$6.69K
Capitalization68.95M
AUTL vs GNTA Comparison Chart in %
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. GNTA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and GNTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (AUTL: $2.41 vs. GNTA: $3.77)
Brand notoriety: AUTL and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 76% vs. GNTA: 40%
Market capitalization -- AUTL: $641.39M vs. GNTA: $68.95M
AUTL [@Biotechnology] is valued at $641.39M. GNTA’s [@Biotechnology] market capitalization is $68.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 0 FA rating(s) are green whileGNTA’s FA Score has 0 green FA rating(s).

  • AUTL’s FA Score: 0 green, 5 red.
  • GNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, AUTL is a better buy in the long-term than GNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 3 TA indicator(s) are bullish while GNTA’s TA Score has 4 bullish TA indicator(s).

  • AUTL’s TA Score: 3 bullish, 5 bearish.
  • GNTA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both AUTL and GNTA are a bad buy in the short-term.

Price Growth

AUTL (@Biotechnology) experienced а -2.43% price change this week, while GNTA (@Biotechnology) price change was -4.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

AUTL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($641M) has a higher market cap than GNTA($69M). AUTL YTD gains are higher at: 2.553 vs. GNTA (-13.333).
AUTLGNTAAUTL / GNTA
Capitalization641M69M929%
EBITDA-226.02MN/A-
Gain YTD2.553-13.333-19%
P/E RatioN/AN/A-
Revenue9.01MN/A-
Total Cash517MN/A-
Total Debt57.7MN/A-
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLGNTA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIOXF14.63N/A
N/A
RION CO LTD.
JCYGY39.76N/A
N/A
Jardine Cycle & Carriage Limited
LEIC0.15N/A
N/A
Lead Innovation Corporation
SECCF2.96N/A
N/A
Serco Group Plc.
BOREF1.71-0.29
-14.50%
Borealis Exploration Limited

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-0.41%
OCUL - AUTL
51%
Loosely correlated
-0.44%
CRSP - AUTL
48%
Loosely correlated
+18.22%
SCPH - AUTL
46%
Loosely correlated
+1.65%
ERAS - AUTL
45%
Loosely correlated
+0.67%
IDYA - AUTL
45%
Loosely correlated
-2.26%
More

GNTA and

Correlation & Price change

A.I.dvisor tells us that GNTA and BEIGF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNTA and BEIGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
-0.26%
BEIGF - GNTA
28%
Poorly correlated
N/A
PTHS - GNTA
25%
Poorly correlated
-8.27%
RLFTF - GNTA
24%
Poorly correlated
-3.60%
SONN - GNTA
22%
Poorly correlated
-20.67%
AUTL - GNTA
21%
Poorly correlated
-0.41%
More